IRLAB-A · IRLAB Therapeutics AB
Market Cap
272.44M SEK
Shares
148.71M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close1.8560 SEK
Open1.8100 SEK
Day1.7760–1.8980 SEK
52W close1.2000–2.9200 SEK
Avg vol 30d1.1M
Last earningsFeb 24, 2027
DataJan 2020–Oct 2026
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 1.2000 SEK
Now 1.8560 SEK · 38%
Range high 2.9200 SEK
vs 200-day avg +18%
vs 50-day avg +11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XSTO:IRLAB-A | -2.3% | +8.5% | +18.5% | +1.6% | -5.8% |
Exchange listing
- Market
- XSTO
- Ticker
- IRLAB-A
- ISIN
- SE0012675361
- Security
- —
- Trading currency
- SEK
Company
- Investor relations
- https://irlab.se/investor-relations/
Other listings of this company
No other verified listings are available.
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
| Date | Event | Type |
|---|---|---|
| 2026-11-13 00:00 UTC | Interim report January - September 2026 | Results publication |
| 2027-02-24 00:00 UTC | Year-end report 2026 | Results publication |
Earnings calls
-
Earnings call · Q4 2026 2027-02-24 ScheduledYear-end report 2026
-
Earnings call · Q3 2026 2026-11-13 ScheduledInterim report January - September 2026